Entocycle
+28%
est. 2Y upside i
Automated factory to produce insect protein for farm animals.
Rank
#1457
Sector
Sustainable Agriculture Technology
Est. Liquidity
~4Y
Data Quality
Data: LowWith an expected 2-year upside of ~28% and low confidence due to data gaps, equity in Entocycle offers moderate potential but carries significant risk from capital intensity and preference overhang.
Last updated: July 19, 2026
With rapid market adoption and IPO window, exit multiple expands to 4x, implying $84M exit, net 76.7% upside after 20% dilution.
Exit multiple converges to 3x, implying $63M exit, net 32.6% upside after 20% dilution, reflecting moderate growth and market validation.
Exit multiple compresses to 2x, implying $42M exit, net -11.6% after dilution; still above preference stack of $21.2M, so common recovers partially.
Preference Stack Risk
severeFunding Intensity
54%Total funding $21.2M is 53.5% of $39.6M valuation, creating severe preference overhang.
Dilution Risk
highHigh capital intensity suggests further funding rounds needed; estimated 20% dilution within 2 years.
Secondary Liquidity
noneNo secondary market available; liquidity only via IPO or acquisition.
Questions to Ask at the Interview
Strategic questions based on Entocycle's data — designed to show you've done your homework.
- 1
“How does Entocycle plan to achieve profitability given high capital intensity?”
- 2
“What is the company's go-to-market strategy for licensing hardware vs selling insect protein?”
- 3
“Given the preference stack, how does the company think about employee equity value?”
Community
Valuation Sentiment
Our model estimates +28% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.